Company-led drug recall: Fosavance® (alendronic acid and colecalciferol)

Source: MHRA Area: News A company-led recall of a batch of Fosavance® (alendronic acid and colecalciferol) has been issued, as 239 packs have been inadvertently parallel distributed in the UK (when intended for the Irish market).  The content of colecalciferol in tablets from this batch is 140mcg whereas the colecalciferol content of the presentation authorised in the UK is 70mcg.   The company is B&S Healthcare and the affected batch is 10F341 (Expiry September 2013). For further details, please see the link below.  
Source: NeLM - News - Category: Drugs & Pharmacology Source Type: news